Biology Reference
In-Depth Information
[162]
Pan, X., Ikeda, S.R., Lewis, D.L. (1996). Rat brain cannabinoid receptor modulates N-
type Ca2+ channels in a neuronal expression system.
Mol Pharmacol
, 49, 707-714.
[163]
Pinto, J.C., Potie, F., Rice, K.C., Boring, D., Johnson, M.R., Evans, D.M., Wilken,
G.H., Cantrell, C.H., Howlett, A.C. (1994). Cannabinoid receptor binding and agonist
activity of amides and esters of arachidonic acid.
Mol. Pharmacol
, 46, 516-522.
[164]
Piomelli, D. (2003). The molecular logic of endocannabinoid signalling.
Nat Rev
Neurosci
, 4, 873-884.
[165]
Pitler, T.A., Alger, B.E. (1990). Activation of the pharmacologically defined M3
muscarinic receptor depolarizes hippocampal pyramidal cells.
Brain Res.
,
534
, 257-
262.
[166]
Pitler, T.A., Alger, B.E. (1992) Postsynaptic spike firing reduces synaptic GABAA
responses in hippocampal pyramidal cells.
J Neurosci
, 12, 4122-4132.
[167]
Pitler, T.A., Alger, B.E. (1994). Depolarization-induced suppression of GABAergic
inhibition in rat hippocampal pyramidal cells: G protein involvement in a presynaptic
mechanism.
Neuron
, 13, 1447-1455.
[168]
Porter, A.C., Sauer, J.M., Knierman, M.D., Becker, G.W., Berna, M.J., Bao, J.,
Nomikos, G.G., Carter, P., Bymaster, F.P., Leese, A.B., Felder, C.C. (2002).
Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at
the CB1 receptor.
J Pharmacol Exp Ther
, 301, 1020-1024.
[169]
Prescott, S.M., Majerus, P.W. (1983). Characterization of 1,2-diacylglycerol hydrolysis
in human platelets. Demonstration of an arachidonoyl-monoacylglycerol intermediate.
J
Biol Chem
, 258, 764-769.
[170]
Robbe, D., Kopf, M., Remaury, A., Bockaert, J., Manzoni, O.J. (2002). Endogenous
cannabinoids mediate long-term synaptic depression in the nucleus accumbens.
Proc
Natl Acad Sci U S A
, 99, 8384-8388.
[171]
Robinson, L., McKillop-Smith, S., Ross, N.L., Pertwee, R.G., Hampson, R.E., Platt, B.,
Riedel, G. (2007). Hippocampal endocannabinoids inhibit spatial learning and limit
spatial memory in rats.
Psychopharmacology (Berl)
.
[172]
Ronesi, J., Gerdeman, G.L., Lovinger, D.M. (2004). Disruption of endocannabinoid
release and striatal long-term depression by postsynaptic blockade of endocannabinoid
membrane transport.
J Neurosci
, 24, 1673-1679.
[173]
Ross, R.A., Craib, S.J., Stevenson, L.A., Pertwee, R.G., Henderson, A., Toole, J.,
Ellington, H.C. (2002). Pharmacological characterization of the anandamide
cyclooxygenase metabolite: prostaglandin E2 ethanolamide.
J Pharmacol Exp Ther
,
301, 900-907.
[174]
Safo, P.K., Regehr, W.G. (2005). Endocannabinoids control the induction of cerebellar
LTD.
Neuron
, 48, 647-659.
[175]
Schabitz, W.R., Giuffrida, A., Berger, C., Aschoff, A., Schwaninger, M., Schwab, S.,
Piomelli, D. (2002). Release of fatty acid amides in a patient with hemispheric stroke: a
microdialysis study.
Stroke
, 3
3, 2112-2114.
[176]
Schmid, P.C., Reddy, P.V., Natarajan, V., Schmid, H.H. (1983). Metabolism of N-
acylethanolamine phospholipids by a mammalian phosphodiesterase of the
phospholipase D type.
J Biol Chem
, 258, 9302-9306.
[177]
Shen, M., Thayer, S.A. (1998). The cannabinoid agonist Win55,212-2 inhibits calcium
channels by receptor-mediated and direct pathways in cultured rat hippocampal
neurons.
Brain Res
, 783, 77-84.
